Korea's SK bioscience plans Ph III COVID-19 vaccine trial in multiple countries

The International Vaccine Institute (IVI) is partnering with SK bioscience of South Korea to conduct Phase III clinical ...

August 11, 2021 | Wednesday | News
China approves first hormone replacement therapy for hypoparathyroidism

On account of World Hypopara Awareness Day on June 1st, VISEN Pharmaceuticals, a biotech company focused on developing a...

June 4, 2021 | Friday | News
GlobalData reports the status of Global COVID-19 vaccine trials

While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...

February 8, 2021 | Monday | Analysis
I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy

I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discovery, devel...

November 25, 2020 | Wednesday | Company results
Gilead’s Biktarvy sustains viral suppression and tolerability in Asian HIV patients

Gilead Sciences, Inc. on 15 Oct 2020 announced findings from multiple studies in Asian population that evaluated th...

October 16, 2020 | Friday | News